KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹18 Cr | ₹-1.53 Cr | ₹2.59 Cr | ₹5.78 Cr | ₹46 Cr |
What is the latest Cash Flow from Operating Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-1.53 Cr |
| Mar2023 | ₹2.59 Cr |
| Mar2022 | ₹5.78 Cr |
| Mar2021 | ₹46 Cr |
How is Cash Flow from Operating Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-1.53 Cr | Negative | |
| Mar2023 | ₹2.59 Cr | -55.28 | |
| Mar2022 | ₹5.78 Cr | -87.33 | |
| Mar2021 | ₹46 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹560.0 Cr | -3% | 2.4% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -3% |
2.4% |
7.6% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses